{"id":379122,"date":"2020-11-11T17:36:13","date_gmt":"2020-11-11T22:36:13","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=379122"},"modified":"2020-11-11T17:36:13","modified_gmt":"2020-11-11T22:36:13","slug":"phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\/","title":{"rendered":"PhaseBio to Present at the Stifel 2020 Virtual Healthcare Conference on November 18th"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwalignl { text-align: left }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>PhaseBio to Present at the Stifel 2020 Virtual Healthcare Conference on November 18<sup>th<\/sup><\/b><\/p>\n<p class=\"bwalignl\">MALVERN, Pa. &amp; SAN DIEGO&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fphasebio.com%2F&amp;esheet=52325571&amp;newsitemid=20201111005906&amp;lan=en-US&amp;anchor=PhaseBio+Pharmaceuticals%2C+Inc.&amp;index=1&amp;md5=599cb633f84b5bb188fb485c56b14fea\">PhaseBio Pharmaceuticals, Inc.<\/a> (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular and cardiopulmonary diseases, today announced that Chief Executive Officer Jonathan P. Mow will participate in a fireside chat during the Stifel 2020 Virtual Healthcare Conference on Wednesday, November 18, 2020, at 11:20 a.m. EST.\n<\/p>\n<p>\nThe event will be available via live webcast from the \u201cEvents and Presentations\u201d page of the \u201cInvestors\u201d section of the company\u2019s website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.phasebio.com%2Fnews-events%2Fevents-and-presentations&amp;esheet=52325571&amp;newsitemid=20201111005906&amp;lan=en-US&amp;anchor=www.phasebio.com&amp;index=2&amp;md5=f2f76b0a90ff06c3f91ba4e5036602b4\">www.phasebio.com<\/a>. The webcast replay will be available for 90 days after the conclusion of the live presentation.\n<\/p>\n<p><b>About PhaseBio<\/b><\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fphasebio.com%2F&amp;esheet=52325571&amp;newsitemid=20201111005906&amp;lan=en-US&amp;anchor=PhaseBio+Pharmaceuticals%2C+Inc.&amp;index=3&amp;md5=8d31b419b46b7396b830751ded8d4546\">PhaseBio Pharmaceuticals, Inc.<\/a> is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular and cardiopulmonary diseases. The company\u2019s pipeline includes: bentracimab (PB2452), a novel reversal agent for the antiplatelet therapy ticagrelor; pemziviptadil (PB1046), a once-weekly vasoactive intestinal peptide receptor agonist for the treatment of pulmonary arterial hypertension; and PB6440, an oral agent for the treatment of resistant hypertension. PhaseBio\u2019s proprietary elastin-like polypeptide technology platform enables the development of therapies with potential for less-frequent dosing and improved pharmacokinetics, including pemziviptadil, and drives both internal and partnership drug-development opportunities.\n<\/p>\n<p>\nPhaseBio is located in Malvern, PA, and San Diego, CA. For more information, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fphasebio.com%2F&amp;esheet=52325571&amp;newsitemid=20201111005906&amp;lan=en-US&amp;anchor=www.phasebio.com&amp;index=4&amp;md5=cf99406cd9ead743d312b16eeff663cd\">www.phasebio.com<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201111005906r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20201111005906\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201111005906\/en\/<\/a><\/span><\/p>\n<p><b>Investor Contact:<br \/>\n<\/b><br \/>John Sharp<br \/>\n<br \/>PhaseBio Pharmaceuticals, Inc.<br \/>\n<br \/>Chief Financial Officer<br \/>\n<br \/>(610) 981-6506<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:john.sharp@phasebio.com\">john.sharp@phasebio.com<br \/>\n<\/a><\/p>\n<p><b>Media Contact:<br \/>\n<\/b><br \/>Will Zasadny<br \/>\n<br \/>Canale Communications, Inc.<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:Will.zasadny@canalecomm.com\">Will.zasadny@canalecomm.com<br \/>\n<\/a><br \/>619-961-8848\n<\/p>\n<p><b>KEYWORDS:<\/b> United States North America California Pennsylvania<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Science Cardiology Other Science Biotechnology Research Pharmaceutical General Health Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20201111005906\/en\/791182\/3\/PhaseBio_Inline_FullColor_RGB.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>PhaseBio to Present at the Stifel 2020 Virtual Healthcare Conference on November 18th MALVERN, Pa. &amp; SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular and cardiopulmonary diseases, today announced that Chief Executive Officer Jonathan P. Mow will participate in a fireside chat during the Stifel 2020 Virtual Healthcare Conference on Wednesday, November 18, 2020, at 11:20 a.m. EST. The event will be available via live webcast from the \u201cEvents and Presentations\u201d page of the \u201cInvestors\u201d section of the company\u2019s website at www.phasebio.com. The webcast replay will be available for 90 days after the conclusion of the live presentation. About PhaseBio PhaseBio Pharmaceuticals, Inc. is a clinical-stage &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;PhaseBio to Present at the Stifel 2020 Virtual Healthcare Conference on November 18th&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-379122","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PhaseBio to Present at the Stifel 2020 Virtual Healthcare Conference on November 18th - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PhaseBio to Present at the Stifel 2020 Virtual Healthcare Conference on November 18th - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PhaseBio to Present at the Stifel 2020 Virtual Healthcare Conference on November 18th MALVERN, Pa. &amp; SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular and cardiopulmonary diseases, today announced that Chief Executive Officer Jonathan P. Mow will participate in a fireside chat during the Stifel 2020 Virtual Healthcare Conference on Wednesday, November 18, 2020, at 11:20 a.m. EST. The event will be available via live webcast from the \u201cEvents and Presentations\u201d page of the \u201cInvestors\u201d section of the company\u2019s website at www.phasebio.com. The webcast replay will be available for 90 days after the conclusion of the live presentation. About PhaseBio PhaseBio Pharmaceuticals, Inc. is a clinical-stage &hellip; Continue reading &quot;PhaseBio to Present at the Stifel 2020 Virtual Healthcare Conference on November 18th&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-11T22:36:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201111005906r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"PhaseBio to Present at the Stifel 2020 Virtual Healthcare Conference on November 18th\",\"datePublished\":\"2020-11-11T22:36:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\\\/\"},\"wordCount\":301,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201111005906r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\\\/\",\"name\":\"PhaseBio to Present at the Stifel 2020 Virtual Healthcare Conference on November 18th - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201111005906r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2020-11-11T22:36:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201111005906r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201111005906r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PhaseBio to Present at the Stifel 2020 Virtual Healthcare Conference on November 18th\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PhaseBio to Present at the Stifel 2020 Virtual Healthcare Conference on November 18th - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\/","og_locale":"en_US","og_type":"article","og_title":"PhaseBio to Present at the Stifel 2020 Virtual Healthcare Conference on November 18th - Market Newsdesk","og_description":"PhaseBio to Present at the Stifel 2020 Virtual Healthcare Conference on November 18th MALVERN, Pa. &amp; SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular and cardiopulmonary diseases, today announced that Chief Executive Officer Jonathan P. Mow will participate in a fireside chat during the Stifel 2020 Virtual Healthcare Conference on Wednesday, November 18, 2020, at 11:20 a.m. EST. The event will be available via live webcast from the \u201cEvents and Presentations\u201d page of the \u201cInvestors\u201d section of the company\u2019s website at www.phasebio.com. The webcast replay will be available for 90 days after the conclusion of the live presentation. About PhaseBio PhaseBio Pharmaceuticals, Inc. is a clinical-stage &hellip; Continue reading \"PhaseBio to Present at the Stifel 2020 Virtual Healthcare Conference on November 18th\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-11T22:36:13+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201111005906r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"PhaseBio to Present at the Stifel 2020 Virtual Healthcare Conference on November 18th","datePublished":"2020-11-11T22:36:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\/"},"wordCount":301,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201111005906r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\/","name":"PhaseBio to Present at the Stifel 2020 Virtual Healthcare Conference on November 18th - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201111005906r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2020-11-11T22:36:13+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201111005906r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201111005906r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phasebio-to-present-at-the-stifel-2020-virtual-healthcare-conference-on-november-18th\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"PhaseBio to Present at the Stifel 2020 Virtual Healthcare Conference on November 18th"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/379122","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=379122"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/379122\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=379122"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=379122"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=379122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}